Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
Current guidelines recommend long-term anticoagulant therapy in patients with unprovoked venous thromboembolism (VTE). The risk of fatal recurrent VTE after treatment discontinuation (versus that of fatal bleeding during anticoagulation) is of particular relevance in the decision to continue or stop...
Main Authors: | Sake J. van der Wall, Liselotte M. van der Pol, Yvonne M. Ende-Verhaar, Suzanne C. Cannegieter, Sam Schulman, Paolo Prandoni, Marc Rodger, Menno V. Huisman, Frederikus A. Klok |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2018-11-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/27/150/180094.full |
Similar Items
-
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
by: Walter Ageno, et al.
Published: (2021-02-01) -
Extended anticoagulation for VTE: what evidence justifies it?
by: Anushka Walia, et al.
Published: (2023-08-01) -
Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
by: Bethany Samuelson Bannow, et al.
Published: (2021-07-01) -
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
by: Wei Xiong, et al.
Published: (2023-01-01) -
VTE epidemiology and challenges for VTE prevention at the population level
by: Sigrid K. Brækkan, et al.
Published: (2023-03-01)